Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.
Holmes J, Hemmett L, Garfield S. Holmes J, et al. Among authors: hemmett l. Eur J Health Econ. 2005 Mar;6(1):30-7. doi: 10.1007/s10198-004-0254-1. Eur J Health Econ. 2005. PMID: 15682286 Review.
A cost-effectiveness analysis of docetaxel in the second-line treatment of non-small cell lung cancer.
Holmes J, Dunlop D, Hemmett L, Sharplin P, Bose U. Holmes J, et al. Among authors: hemmett l. Pharmacoeconomics. 2004;22(9):581-9. doi: 10.2165/00019053-200422090-00003. Pharmacoeconomics. 2004. PMID: 15209527
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK.
Moeremans K, Hemmett L, Hjelmgren J, Allegri G, Smets E. Moeremans K, et al. Among authors: hemmett l. Pharmacoeconomics. 2010;28 Suppl 1:147-67. doi: 10.2165/11587500-000000000-00000. Pharmacoeconomics. 2010. PMID: 21182349
What drives quality of life in multiple sclerosis?
Hemmett L, Holmes J, Barnes M, Russell N. Hemmett L, et al. QJM. 2004 Oct;97(10):671-6. doi: 10.1093/qjmed/hch105. QJM. 2004. PMID: 15367738
Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER.
Hill AM, Gebo K, Hemmett L, Löthgren M, Allegri G, Smets E. Hill AM, et al. Among authors: hemmett l. Pharmacoeconomics. 2010;28 Suppl 1:169-81. doi: 10.2165/11587510-000000000-00000. Pharmacoeconomics. 2010. PMID: 21182350
Analysis of costs by CD4 count category for the darunavir/r 600/100 mg bid and control protease inhibitor arms of the POWER 1 and 2 trials.
Hill A, Hemmett L, Wilson B. Hill A, et al. Among authors: hemmett l. HIV Clin Trials. 2007 Sep-Oct;8(5):303-10. doi: 10.1310/hct0805-303. HIV Clin Trials. 2007. PMID: 17956831
Needs assessment of women with urinary incontinence in a district health authority.
MacKay K, Hemmett L. MacKay K, et al. Among authors: hemmett l. Br J Gen Pract. 2001 Oct;51(471):801-4. Br J Gen Pract. 2001. PMID: 11677702 Free PMC article.
Feedback